[1]Locationinpatent:experimentalpartDiakos,ConnieI.;Zhang,Mei;Beale,PhilipJ.;Fenton,RonaldR.;Hambley,TrevorW.[EuropeanJournalofMedicinalChemistry,2009,vol.44,#7,p.2807-2814]
2227199-06-4
125224-62-6
155206-39-6
155726-05-9
2007924-98-1
21043-40-3
116986-12-0 | 2-(Bromomethyl)nicotinonitrile | AA000DDN | MFCD15526689
117103-53-4 | 2-Bromo-5-nitropyrazine | AA000DO3 | MFCD11870741
1172965-47-7 | 2-(3-Methoxyphenyl)-2-oxoacetaldehyde hydrate | AA000DZ4 | MFCD06800953
1174229-72-1 | Ethyl 2-(6-aminopyridin-3-yl)acetate | AA000E7E | MFCD20703180
1146699-66-2 | Bms-708163 | AA000EX4 | MFCD13195458
114873-06-2 | Boc-3-methyl-L-phenylalanine | AA000FB3 | MFCD01862944
1150114-75-2 | 6-(Pyrrolidin-1-yl)pyridine-3-boronic acid | AA000FKC | MFCD06801704
1150561-74-2 | 3-Amino-2-chloropyridine-6-boronic acid, pinacol ester | AA000FPZ | MFCD11044433
115570-52-0 | Neopentyl glycol bis(4-aminophenyl) ether | AA000G3W | MFCD00671569
115270-11-6 | Carbamic acid, N-[(2E)-3-phenyl-2-propen-1-yl]-, 1,1-dimethylethyl ester | AA000GG5 | MFCD29917048